Intrathecal chemical neurolysis for intractable cancer pain: a retrospective audit of 39 patients at a specialized cancer centre

Abstract

Objectives: Treatment of cancer pain presents a challenging problem. Up to 90% of cancer patients can be treated with conventional pharmacological therapy. The remaining 10% of patients require additional interventions for management of their pain. Intrathecal chemical neurolysis(ICN) is a beneficial intervention in management of cancer pain. The primary objective of this study was to study the effects of pain relief of ICN on the Visual Analogue Score (VAS) of patients with metastatic cancer disease on palliative therapy.